Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Suzhou Hearthill Medical Technology is a Chinese medical device company specializing in the development of innovative transcatheter structural heart therapies. Based in the Suzhou Industrial Park, the company focuses on minimally invasive solutions for valvular heart diseases, including transcatheter aortic valve replacement (TAVR) and mitral valve repair systems. Their portfolio aims to provide high-performance, cost-effective alternatives to traditional open-heart surgery for patients with complex cardiovascular conditions. The company is led by experienced professionals from the interventional cardiology industry and maintains a strong focus on R&D and clinical validation. Hearthill Medical's technologies are designed to address the growing clinical needs of the aging population in China and globally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Suzhou Hearthill Medical Technology.